Related Experiment Videos
A financial analysis of Hodgkin lymphoma staging
Insights
Thirty percent of Hodgkin lymphoma staging costs were excessive. Reducing hospitalization is key to lowering these expenses, especially when treatment decisions are delayed.
Area of Science:
- Oncology
- Health Economics
Background:
- Hodgkin lymphoma staging involves complex clinical algorithms.
- Accurate cost assessment is crucial for healthcare management.
Purpose of the Study:
- To analyze charges associated with Hodgkin lymphoma staging.
- To identify areas of perceived excess cost within the staging process.
Main Methods:
- A clinical algorithm for Hodgkin disease staging was applied.
- Charges for 50 patients at a university hospital were categorized: necessary, justifiable, and perceived excess.
- Correlation analysis was performed between excess costs and time to treatment decision.
Main Results:
- Thirty percent of total staging charges were identified as perceived excess.
- Hospitalization (68%) and laboratory charges (22%) constituted the majority of excess costs.
- Excess medical hospitalization correlated positively with delayed treatment decisions.
Conclusions:
- Significant excess charges exist in Hodgkin lymphoma staging.
- Reducing hospitalization is a primary strategy for cost containment.
- Streamlining the staging process, particularly reducing delays, can mitigate unnecessary expenses.
Abstract:
A clinical algorithm was developed for staging of Hodgkin disease. This represented the treatment logic employed in a specified time period and was used to categorize charges incurred in the staging of 50 consecutive patients who underwent this process at a university hospital. Charges were categorized as: necessary (in concordance with the algorithm), justifiable (a result of care for a separate medical disorder or for consideration of distance), and perceived excess (neither necessary nor justifiable). Thirty per cent of the total charges were identified as perceived excess. Hospitalization accounted for 68 per cent and laboratory charges 22 per cent of the perceived excess charges. Fifty-eight per cent of the patients had a percentage of perceived excess bed charges exceeding 30 per cent of the total. Perceived excess medical hospitalization correlated positively with time from diagnosis to treatment decision. It is recommended that attempts to reduce the expense of Hodgkin lymphoma staging be directed at decreasing hospitalization.